|
Volumn 2, Issue 3, 2002, Pages 183-187
|
Clinical pathways in treatment of asthma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIASTHMATIC AGENT;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CORTICOSTEROID;
CROMOGLYCATE DISODIUM;
IPRATROPIUM BROMIDE;
PREDNISONE;
SALBUTAMOL;
ADULT;
ASTHMA;
CHILD;
CLINICAL PATHWAY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG PREFERENCE;
HEALTH CARE COST;
HOSPITAL ADMISSION;
HUMAN;
LENGTH OF STAY;
MAJOR CLINICAL STUDY;
PATIENT SATISFACTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT DISEASE;
REVIEW;
TREATMENT OUTCOME;
|
EID: 0036275390
PISSN: 15284050
EISSN: None
Source Type: Journal
DOI: 10.1097/00130832-200206000-00005 Document Type: Review |
Times cited : (15)
|
References (22)
|